Daratumumab monotherapy for relapsed POEMS syndrome

Am J Hematol. 2023 Nov;98(11):E291-E294. doi: 10.1002/ajh.27050. Epub 2023 Aug 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents* / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols
  • Humans
  • Multiple Myeloma* / drug therapy
  • Neoplasm Recurrence, Local / drug therapy
  • POEMS Syndrome* / drug therapy

Substances

  • daratumumab
  • Antibodies, Monoclonal
  • Antineoplastic Agents